Europe Medical Second Opinion Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.
The Europe Medical Second Opinion Market size was valued at US$ 1,652.44 Mn in 2023 and is projected to reach US$ 4,714.17 Mn by 2031, growing at a CAGR of 14.0% during 2023 - 2031.
Report Coverage
- Condition: Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematological Blood Disorders, COPD, Organ Transplant, Others
- Service Provider: Hospitals, Health Insurance Companies, Online Services
US$ 1,652.44 Mn
Market size in 2023
US$ 4,714.17 Mn
Market Size by 2031
14.0%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Medical Second Opinion Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Medical Second Opinion Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Medical Second Opinion Market Regional Analysis
6.2 Europe Medical Second Opinion Market Revenue 2021-2031 (US$ Million)
6.3 Europe Medical Second Opinion Market Forecast Analysis
7. Europe Medical Second Opinion Market Analysis – by Condition
7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Hematological Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Blood Disorders: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Organ Transplant
- 7.8.1 Overview
- 7.8.2 Organ Transplant: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Medical Second Opinion Market Analysis – by Service Provider
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services: Europe Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Medical Second Opinion Market – Europe Analysis
9.1 Overview
9.2 Europe- 9.2.1 Europe Medical Second Opinion Market Breakdown, by Key Country, 2024 and 2031 (%)
- 9.2.1.1 Europe Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 Germany: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.1.1 Germany: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.1.2 Germany: Europe Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.2 France: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.2.1 France: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.2.2 France: Europe Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.3 Italy: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.3.1 Italy: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.3.2 Italy: Europe Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.4 UK: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.4.1 UK: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.4.2 UK: Europe Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.5 Spain: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.5.1 Spain: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.5.2 Spain: Europe Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.6 Rest of Europe: Europe Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.6.2 Rest of Europe: Europe Medical Second Opinion Market Breakdown, by Service Provider
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Second Opinion International
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elite Medical Services
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 The Cigna Group
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Helsana
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WorldCare
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Vidal Health Insurance TPA Pvt Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 2nd.MD
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Axa SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Teladoc Health Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Included Health, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Royal Doctors
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
